hYAK3-2 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing hYAK3-2 polypeptides and polynucleotides in the design of protocols for the treatment of bone loss including osteoporosis; inflammatory diseases such as Adult Respiratory Disease Syndrome (ARDS), Rheumatoid arthritis, Osteoarthritis, Inflammatory Bowel Disease (IBD), psoriasis, dermatitis, asthma, allergies; infections such as bacterial, fungal, protozoan and viral infections, particularly infections caused by HIV-1 or HIV-2; HIV-associated cachexia and other immunodeficiency disorders; septic shock; pain; injury; cancers including testicular cancer; anorexia; bulimia; neutropenia; cytopenia; anemias, including anemias due to renal insufficiency or to chronic disease, such as autoimmunity or cancer, and drug-induced anemias; polycythemia; myelosuppression; Parkinson's disease; cardiovascular disease including restenosis, atherosclerosis, acute heart failure, myocardial infarction; hypotension; hypertension; urinary retention; angina pectoris; ulcers; benign prostatic hypertrophy; and psychotic and neurological disorders, including anxiety, schizophrenia, manic depression, delirium, dementia, severe mental retardation and dyskinesias, such as Huntington's disease or Gilles dela Tourett's syndrome, among others, and diagnostic assays for such conditions.

i polipeptidi hYAK3-2 ed i polynucleotides ed i metodi per produrre tali polipeptidi mediante tecniche recombinant sono rilevati. Inoltre sono rilevati i metodi per l'utilizzazione i polipeptidi hYAK3-2 e dei polynucleotides nel disegno dei protocolli per il trattamento di perdita dell'osso compreso osteoporosis; malattie infiammatorie quale la sindrome respiratoria di malattia dell'adulto (ARDS), artrite rheumatoid, osteoartrite, malattia infiammatoria delle viscere (IBD), psoriasis, dermatite, asma, allergie; infezioni come batterico, fungoso, protozoan ed infezioni virali, specialmente infezioni causate da HIV-1 o HIV-2; cachessia HIV-collegata ed altri disordini di immunodeficiency; scossa settica; dolore; ferita; cancri compreso cancro testicolare; anorexia; bulimia; neutropenia; cytopenia; anemias, compreso i anemias dovuto insufficienza renale o alla malattia cronica, quali autoimmunità o cancro ed anemias droga-indotti; polycythemia; myelosuppression; Malattia del Parkinson; malattia cardiovascolare compreso il restenosis, aterosclerosi, guasto di cuore acuto, infarto miocardico; hypotension; ipertensione; ritegno urinario; angina pectoris; ulcere; ipertrofia prostatic benigna; e disordini psicotici e neurologici, compreso ansia, schizofrenia, la depressione manic, il delirium, la demenza, il ritardo mentale severo e le discinesie, quale la sindrome del Tourett di malattia del Huntington o di dela di Gilles, tra altre ed analisi diagnostiche per tali circostanze.

 
Web www.patentalert.com

< (none)

< Method, computer program product, and data structure for publishing a data object over a store and forward transport

> Concentrated, stable fabric softening composition

> (none)

~ 00021